Loading...
Loading...
Among the 5 tracked institutional investors we monitor, PDSB (PDS BIOTECHNOLOGY CORP) is held with a combined value of $2.06M across 2,870,427 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.50M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 2 funds increased their holdings.
Total Institutional Value
$2.06M
Total Shares Held
2,870,427
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.50M | 0.00% | New |
| 2 | BlackRock, Inc. | $335.20K | 0.00% | +6.1% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $133.58K | 0.00% | +25.0% |
| 4 | STATE STREET CORP | $80.67K | 0.00% | - |
| 5 | CITADEL ADVISORS LLC | $6.84K | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of PDSB with a position worth $1.50M, representing 0.00% of their portfolio. In total, 5 institutional investors hold PDSB with a combined value of $2.06M.
In the most recent quarter, 2 funds opened a new position in PDSB. Additionally, 2 increased their holdings.
Institutional investors hold $2.06M worth of PDSB stock across 5 positions. The largest institutional holder is VANGUARD GROUP INC with $1.50M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For PDSB, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their PDSB positions.